Sharepoint Solutions
PRODUCTS
-
![GettyImages-2161842577-business-professional-laptop-office-table]( "Medical Writing Software")
Accelerate Medical Writing Without Compromising Accuracy or Compliance
In the fast-paced world of clinical research, the ability to produce, review, and finalize high-quality documents—on time and with full regulatory compliance—is non-negotiable. Ideagen Document Review (formerly known as PleaseReview) is the trusted collaboration and co-authoring platform that enables clinical teams to streamline document reviews, reduce version chaos, and ensure traceable, auditable feedback across the board.
-
![GettyImages-1294339649 drug development, cleanroom]( "Small Molecule Contract Development And Manufacturing Services")
SMALL MOLECULE SYNTHESIS, FROM PRECLINICAL TO COMMERCIAL QUANTITIES
With Millipore® CTDMO Services we support small molecule API synthesis projects from milligram to commercial quantities. We are the partner to address the most difficult challenges, whether the target is difficult to handle, synthesize, or source. With a true consultative and partnered approach, our services reduce complexity and minimize program risk in a cost-effective manner.
-
![GettyImages-2008259193-manufacturing-tablet-control-gear]( "Make Traceability A Seamless Part Of Your Operations")
Take control of your production by tracking every part, assembly, and batch with precision.
-
![3P Innovation - compression blister platform]( "Compression Blister Filler")
Forming part of 3P innovation’s Discover Range, this early-stage development unit uses two sets of die punches to compress pellets and seal them within a blister strip. Used predominantly for dry powder inhalers (DPIs), the ultra-compact filler fits on your lab benchtop.
-
![GettyImages-1387090964 cell and gene therapy]( "Operationalize Cell & Gene Therapies")
As you aim to bring your advanced therapies to patients in need, partnering to overcome the associated regulatory, manufacturing, and logistical complexities is essential to avoid unnecessary costs and delays.
WHITE PAPERS AND CASE STUDIES
-
![Outsourcing Business Human Resources--GettyImages-1305829382]( "Enabling CDMOs To Focus On Core Priorities")
Enabling CDMOs To Focus On Core PrioritiesExplore innovative solutions for CDMO's striving to remain competitive as the biopharmaceutical market grows and evolves.
-
![Chrom-Campaign-LSC-V6-Newsletter-B-450x300px]( "Optimizing End-To-End Processes To Reduce Costs And Improve Yields")
Optimizing End-To-End Processes To Reduce Costs And Improve YieldsExplore the challenges faced by a large CDMO as well as the solutions that were provided to achieve significant time savings, cost savings, and the removal of a major downstream process limitation.
-
![GettyImages-1039397968 trial timing]( "Partnering For Precision In An IPF Study: Securing Timely Deliverables And Key Endpoints")
Partnering For Precision In An IPF Study: Securing Timely Deliverables And Key EndpointsA pharmaceutical company enlisted Worldwide Clinical Trials to help achieve on-time results for their Phase IIa IPF clinical trial, enabling them to manage vendors and meet challenging deadlines.
-
![stevanatogroup_light_obscuration]( "Container Selection For A Highly Sensitive Drug Product: A Success Story")
Container Selection For A Highly Sensitive Drug Product: A Success StoryLearn about the importance of selecting the right container for sensitive drug products and how close collaboration is crucial for avoiding commercialization delays and safety risks to patients.
-
![GettyImages-1997398639-clipboard-paper-review-pen-doctor-office]( "A Strategic Guide For Biotech And Biopharma Leaders")
A Strategic Guide For Biotech And Biopharma LeadersSecuring drug approval is a complex, high-stakes process, and outdated review workflows hinder progress. Explore modern solutions that accelerate timelines without compromising compliance or quality.
-
![Horizontal Optical Comparator]( "Inspecting On The Edge — Understanding Punch Tip Wear")
Inspecting On The Edge — Understanding Punch Tip WearWhy is a horizontal optical comparator highly recommended for tablet manufacturers as a measuring tool for punch tip inspection, and what strategies can be used to detect, reduce, and prevent tip wear?
-
![GettyImages-2150364155-hand-digital-documents-validation]( "Navigating Digital Transformation For Pharmaceutical CDMOs")
Navigating Digital Transformation For Pharmaceutical CDMOsDiscover how CDMOs can modernize operations, safeguard data integrity, and improve audit readiness with practical strategies for connecting systems and reducing validation burdens.
-
![GettyImages-1352603244-laptop-man-typing-technology-office]( "eSource Purpose Is Not Just To Complete The EDC")
eSource Purpose Is Not Just To Complete The EDCCentral eSource transforms data capture from a passive, back-end chore into an active, real-time quality and compliance engine—delivering benefits that extend beyond faster EDC feeds and reduced SDV.
-
![GettyImages-1401269015 data computer]( "Biostatistics And Programming — More Than Just Clinical Trials")
Biostatistics And Programming — More Than Just Clinical TrialsSee how our biostatisticians and programmers successfully ingested, cleaned, and analyzed the data, ultimately providing a small biotech company with several interesting and actionable measures.
-
![GettyImages-1465073112-tablet-pill-OSD]( "Project Management And Strategic Planning Services")
Project Management And Strategic Planning ServicesRead about the steps that led to a progressive drug design and development organization gaining approval to begin manufacturing its new, real-time release, OSD drug in-house.
-
![digital transformation-Digitization of Analog Information-GettyImages-867312356]( "Digitalizing Batch Records In Pharmaceutical Production")
Digitalizing Batch Records In Pharmaceutical ProductionPharma manufacturing embraces cutting-edge automation, yet outdated paper-based documentation hinders efficiency and delays batch releases. See how digital solutions can transform compliance.
-
![GettyImages-1206365639 consent]( "Research Site Network Enhances Study Startup With Reliable ICF Writing Services")
Research Site Network Enhances Study Startup With Reliable ICF Writing ServicesWith help from a new informed consent form (ICF) writing partner, discover how CenExel Clinical Research was able to streamline processes and launch new studies faster.
NEWS
-
NEW Group Itinerary Builder Developed By UrVenue + Club Med To Debut At HITEC6/24/2024
A new tool developed by UrVenue and Club Med will be unveiled this week at HITEC, held now through June 27 at the Charlotte (N.C.) Convention Center
-
Avance Clinical Expands Specialist CNS, Cardiometabolic, And Rare Diseases CRO Services In Europe With Julius Clinical5/28/2024
Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs has signed a Memorandum of Understanding (MOU) with Julius Clinical, a leading CNS, cardiometabolic, and rare diseases specialist CRO with extensive site relationships in the region.
-
Biden-Harris Administration Announces Over $125M For Georgia Drinking Water, Wastewater And Stormwater Infrastructure Upgrades As Part Of President Biden's Investing In America Agenda2/23/2024
The U.S. Environmental Protection Agency (EPA) announced over $125M from President Biden’s Investing in America agenda for Georgia drinking water and clean water infrastructure upgrades.
-
Spraying Methyl Jasmonate On Fruit Trees Boosts Harvest2/26/2025
Spraying persimmon trees with methyl jasmonate (MeJA) can result in healthier, longer lasting fruit, with increased antioxidants a new Edith Cowan University (ECU) study has found.
-
Biofrontera Inc. Announces FDA Filing Of Supplemental New Drug Application For Ameluz To Permit Up To Three Tubes Per Use2/5/2024
Biofrontera Inc. ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, today announced that the U.S. Food and Drug Administration (FDA) has issued a "no filing review issues identified" letter regarding the sNDA (supplementary New Drug Application) submitted by its licensor Biofrontera Bioscience GmbH to increase the maximally approved dosage from one to three tubes of Ameluz per treatment.